Filing Details

Accession Number:
0001567619-21-022717
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-30 18:01:28
Reporting Period:
2021-12-28
Accepted Time:
2021-12-30 18:01:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856380 T. John Treace C/O Treace Medical Concepts, Inc.
203 Fort Wade Road, Suite 150
Ponte Vedra FL 32081
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-28 19,760 $16.99 5,425,655 No 4 S Direct
Common Stock Disposition 2021-12-29 3,075 $17.01 5,422,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,605,000 Indirect By Wife
Common Stock 1,471,250 Indirect By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020
Common Stock 1,839,063 Indirect As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020
Common Stock 408,816 Indirect As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021
Footnotes
  1. Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.585 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $ $17.06 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  5. The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.